If this complexity is properly understood, targeted strategies, including body composition optimization, glycemic control, and lipid modulation, could be leveraged to improve immunotherapy efficacy and patient prognosis
When Serena Williams revealed her use of GLP-1s in an advertisement for telehealth provider Ro, she was defiant: Im not afraid to say it and say it loud. But what she didnt say loudly, or even quietly, was the list of side effects and challenges that come with the use of GLP-1s
First, it inhibits tyrosinase the enzyme involved in melanin synthesis consequently moderating melanin production and supporting a more even complexion
You might feel fine, but the lab results can show a different story
PSM produced two very well matched cohorts of 4063 patients each, who initiated GLP-1RA or BI after an average of 2.5 other diabetes drug classes
BertolloAGMingotiMEDIgncioZM